Certified by Founder Lodge
CatalYm GmbH
Germany - Martinsried, Bayern
START UP
1 Disclosed Funding Rounds $150,000,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Developing innovative immunotherapies to transform cancer patients’ lives by engaging their own immune systems.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 16 ,2024 | Series D | $150,000,000 |
Canaan
Gilde Healthcare
Omega Funds
Bioqube Ventures
JEITO
Brandon Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
